Modern diabetes devices for continuous blood sugar measuring: Limitations due to contact allergies. (9th November 2021)

• Record Type: Journal Article
• Authors: Kamann, Stefanie; Wagner, Nicola; Oppel, Eva
• Is Part Of: Journal der Deutschen Dermatologischen Gesellschaft. Volume 19:Number 12(2021)
• Page Start: 1715
• Page End: 1721
• Publication Date: 2021-11-09
• Subjects: Skin -- Diseases -- Periodicals; Dermatology -- Periodicals; 616.5005
• DOI: 10.1111/ddg.14621
• Languages: English
• ISSNs: 1610-0379

Abstract

Summary: During the past years, diabetes diseases have increased significantly worldwide. However, new technologies such as continuous glucose measurement using a subcutaneous sensor are developing just as rapidly. A continuous improvement in insulin pump therapy is also contributing to an improved quality of life. A common feature of these modern devices for diabetes therapy is that they remain fixed in place on the skin for several days. In recent years, skin reactions, in particular pronounced contact dermatitis due to the devices and their adhesives have been increasingly reported. In particular, isobornyl acrylate, which used to be included in a glucose measurement sensor set, was identified as a main allergen. Development of contact allergy can result both in a necessity to quit the measuring system and in allergic cross‐reactions to other systems.